Application 065287
- Type
- ANDA
- Sponsor
- LARKEN LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | TABLET;ORAL | EQ 20MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54879-025 | Doxycycline Hyclate | Doxycycline Hyclate | STI Pharma LLC | ANDA | Current |
| 68047-714 | Doxycycline Hyclate | Doxycycline Hyclate | Larken Laboratories, Inc. | ANDA | Current |
| 68047-714 | Doxycycline Hyclate | Doxycycline Hyclate | Larken Laboratories, Inc. | ANDA | Current |
| 68047-714 | Doxycycline Hyclate | Doxycycline Hyclate | Larken Laboratories, Inc. | ANDA | Current |
| 68047-714 | Doxycycline Hyclate | Doxycycline Hyclate | Larken Laboratories, Inc. | ANDA | Current |
| 68047-714 | Doxycycline Hyclate | Doxycycline Hyclate | Larken Laboratories, Inc. | ANDA | Current |